Yashica Pharmaceuticals
Yashica Pharmaceuticals
Yashica Pharmaceuticals

Yashica Pharmaceuticals


Yashica PharmaceuticalsYashica Pharmaceuticals

Home » Finished Formulation » Tramadol Hydrochloride Injection

Tramadol Hydrochloride Injection

The Yashidol Injection is a centrally acting analgesic and has an antitussive effect. In contrast to morphine, analgesic doses of Tramadol over a wide range have no respiratory depressant effect. Also gastrointestinal motility is less affected. Effects on the cardiovascular system tend to be slight. Each injection includes 50 mg of tramadol hydrochloride. The injection ampoules are delivered in tamper-proof packaging to maintain the quality during the transportation.

  • Each mL contains: tramadol hydrochloride BP 50 mg
  • Opioid receptor agonist and enantiomer
  • Noradrenaline reuptake inhibitor
  • Analgesic
Molecular formula:
  • C16H26ClNO2
Molecular weight:
  • 299.80
  • Tramadol hydrochloride is an opioid analgesic. It also has noradrenergic and serotonergic properties that may contribute to its analgesic activity. Tramadol is used for moderate to severe pain.
Dosage & administration:
  • Yashidol injection is given by intravenous route. The intramuscular route may also be used. It may also be given by infusion or as part of patient-controlled analgesia system. A dose of 50 to 100 mg may be given every 4 to 6 hours by intramuscular or intravenous injection over 2 to 3 minutes or by intravenous infusion. For the treatment of postoperative pain, the initial dose is 100 mg followed by 50 mg every 10 to 20 minutes if necessary to a total maximum (including the initial dose) of 250 mg in the first hour. Thereafter, doses are 50 to 100mg every 4 to 6 hours up to a total daily dose of 600 mg.
  • Hypotension
  • Alcohol and psychotropic intoxication
  • Hypersensitivity
Adverse effects:
  • Nausea
  • Vomiting and dizziness
Special precautions:
  • Alcohol
  • Not to drive and operate machinery
  • Carbamazepine: A significant increase in tramadol metabolism. Hypnotics, tranquilizers and other
  • Carbamazepine: A significant increase in tramadol metabolism. Hypnotics, tranquilizers and other
  • Hypnotics, tranquilizers and other CNS depressants: Sedative effects potentiated
  • MAOIs: Fatal interaction occurs
  • Opioid analgesics like Buprenorphine, Butorphanol and
    May precipitate withdrawal symptoms.
  • Tranquilizers: Analgesia potentiated.
  • Store between temperature 8℃ and 25℃
  • Protect from light
  • Keep out of reach of children
  • 10 ampoules of 2 mL in a plastic tray packed in printed carton

Yes! I am Interested

Yashica Pharmaceuticals

Our Product Range :     Active Pharmaceuticals Ingredients |Drug Intermediates | Finished Formulation

Home|About Us|Our Product Range|Media Gallery|Contact Us|Enquiry

Member INDIAMART© Yashica Pharmaceuticals Private Limited. All Rights Reserved (Terms of Use)
Developed and Managed by IndiaMART InterMESH Limited

Looking for Product Name ?


Send SMS Enquiry

*Please Enter Requirment

*Please Enter valid Mobile Number

*Please Enter Proper Name